Tetsuya Tanimoto, M.D. Medical Governance Research Institute, Tokyo, Japan On November 2, 2025, the "20th Symposium of the Association for Promoting Healthcare Reform from the Frontlines" in Tokyo convened a session examining conflicts of interest and the flow of pharmaceutical money — such as lecture fees or manuscript compensations — from pharmaceutical corporations and medical device manufacturers to physicians. Drawing upon my presentation delivered at this symposium, thi